Connie L Finstad

This inventor holds 4 USPTO granted patents. Top assignee: Sloan-Kettering Institute for Cancer Research. Active years: 1986-1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Connie L Finstad. Retrieved from https://idiyas.com/inventor/connie-l-finstad

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 100.0

Average Co-Inventor Count = 7.5

ph-index = 2

Forward Citations = 82(Granted Patents)

Company Filing History:

4 out of 519

Sloan-Kettering Institute for Cancer Research

patents

Years Active: 1986-1992

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5168043 - Blood group antigen panel (1992-12-01),

2. 4935344 - Method for characterizing types of renal carcinoma and prognosis (1990-06-19),

3. 4650756 - Monoclonal antibodies to cell surface antigens of human renal cancer (1987-03-17),

4. 4579827 - Monoclonal antibodies to human gastrointestinal cancers and hybridoma (1986-04-01),

Title: The Innovative Journey of Connie L Finstad

Introduction: Connie L Finstad is a pioneering inventor based in New York, NY, known for her groundbreaking contributions to various industries.

Latest Patents: Connie L Finstad holds several patents in the fields of technology and healthcare, showcasing her continuous dedication to innovation.

Career Highlights: With a career spanning over two decades, Connie L Finstad has established herself as a prominent figure in the world of inventions, with a focus on improving people's lives through her creations.

Collaborations: Throughout her career, Connie L Finstad has collaborated with leading research institutions, universities, and companies to bring her innovative ideas to life, further solidifying her reputation as a visionary inventor.

Conclusion: Connie L Finstad's relentless pursuit of innovation and her passion for creating solutions to complex problems have cemented her legacy as a trailblazing inventor in the industry.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]